The binding of lactoferrin to glycosaminoglycans on enterocyte-like HT29-18-C1 cells is mediated through basic residues located in the N-terminus

Groves, 1960, The isolation of a red protein from bovine milk, J. Am. Chem. Soc., 82, 3345, 10.1021/ja01498a029

Masson, 1966, An iron-binding protein common to many external secretions, Clin. Chim. Acta, 14, 735, 10.1016/0009-8981(66)90004-0

Mason, 1978, Distribution of transferrin, ferritin, and lactoferrin in human tissues, J. Clin. Pathol., 31, 316, 10.1136/jcp.31.4.316

Spik, 1982, Characterization and properties of the human and bovine lactotransferrins extracted from faeces of newborn infants, Acta Paediatr. Scand., 71, 979, 10.1111/j.1651-2227.1982.tb09560.x

Harada, 1999, Characteristic transport of lactoferrin from intestinal lumen into bile via the blood in piglets, Comp. Biochem. Physiol. A Mol. Integr. Physiol., 124, 321, 10.1016/S1095-6433(99)00122-1

Hegnhoj, 1986, Duodenal output of lactoferrin in normal subjects and correlation to output of amylase, bicarbonate, and total bile acids, Scand. J. Gastroenterol., 21, 705, 10.3109/00365528609011104

Gaia, 1985, Duodenal lactoferrin in patients with chronic pancreatic and gastrointestinal diseases, Digestion, 32, 229, 10.1159/000199242

Mikogami, 1994, Apical to basolateral transcytosis of human lactoferrin in human differentiated colon carcinoma cell clone HT29 CL 19A, Am. J. Physiol., 267, G308

Mikogami, 1995, Effect of intracellular iron depletion by picolinic acid on expression of lactoferrin receptor in the human colon carcinoma cell subclone HT29-18-C1, Biochem. J., 308, 391, 10.1042/bj3080391

Tomita, 1998, Host defensive effects of orally administered bovine lactoferrin, Adv. Exp. Med. Biol., 443, 189, 10.1007/978-1-4757-9068-9_22

Harmsen, 1995, Antiviral effect of plasma and milk protein: lactoferrin a potent activity against both human immunodeficiency virus and human cytomegalovirus replication in vitro, J. Infect. Dis., 172, 280, 10.1093/infdis/172.2.380

Nichols, 1990, Iron is not required in the lactoferrin stimulation of thymidine incorporation into the DNA of rat crypt enterocytes, Pediatr. Res., 27, 525, 10.1203/00006450-199005000-00022

Cox, 1979, Iron binding proteins and influx of iron across the duodenal brush border. Evidence for specific lactotransferrin receptors in the human intestine, Biochim. Biophys. Acta, 588, 120, 10.1016/0304-4165(79)90377-5

Hu, 1988, Lactotransferrin receptor of mouse small intestinal brush border: binding characteristics of membrane-bound and Triton X-100 solubilized form, Biochem. J., 249, 435, 10.1042/bj2490435

Hu, 1990, Isolation and partial characterization of a lactotransferrin receptor from mouse intestinal brush-border, Biochemistry, 29, 535, 10.1021/bi00454a030

Pierce, 1991, Molecular cloning and sequence analysis of bovine lactotransferrin, Eur. J. Biochem., 196, 177, 10.1111/j.1432-1033.1991.tb15801.x

Metz-Boutigue, 1984, Human lactotransferrin: amino acid sequence, and structural comparisons with other transferrins, Eur. J. Biochem., 145, 659, 10.1111/j.1432-1033.1984.tb08607.x

Rey, 1990, Complete nucleotide sequence of human mammary gland lactoferrin, Nucleic Acids Res., 18, 5288, 10.1093/nar/18.17.5288

Mazurier, 1989, Expression of human lactotransferrin receptors in phytohemagglutinin-stimulated human peripheral blood lymphocytes. Isolation of the receptors by antiligand-affinity chromatography, Eur. J. Biochem., 179, 481, 10.1111/j.1432-1033.1989.tb14578.x

Legrand, 1992, Molecular interactions between human lactotransferrin and the phytohemagglutinin-activated human lymphocyte lactotransferrin receptor lie in two loop-containing regions of the N-terminal domain of human lactotransferrin, Biochemistry, 31, 9243, 10.1021/bi00153a018

Huettinger, 1992, Lactoferrin specifically inhibits endocytosis of chylomicron remnants but not alpha-macroglobulin, J. Biol. Chem., 267, 18551, 10.1016/S0021-9258(19)36997-2

Ziere, 1993, Removal of 14 N-terminal amino acids of lactoferrin enhances its affinity for parenchymal liver cells and potentiates the inhibition of beta-very low density lipoprotein binding, J. Biol. Chem., 268, 27069, 10.1016/S0021-9258(19)74219-7

Wu, 1995, Characterization of the glycosaminoglycan-binding region of lactoferrin, Arch. Biochem. Biophys., 317, 85, 10.1006/abbi.1995.1139

Van Berkel, 1995, Glycosylated and unglycosylated human lactoferrins both bind iron and show identical affinities towards human lysozyme and bacterial lipopolysaccharides but differ in their susceptibilities towards tryptic proteolysis, Biochem. J., 312, 107, 10.1042/bj3120107

Legrand, 1997, The N-terminal Arg2, Arg3 and Arg4 of human lactoferrin interact with sulfated molecules but not with the receptor present on Jurkat human lymphoblastic T-cells, Biochem. J., 327, 841, 10.1042/bj3270841

Elass-Rochard, 1995, Lactoferrin-lipopolysaccharide interaction: involvement of the 28-34 loop region of human lactoferrin in the high-affinity binding to Escherichia coli 055B5 lipopolysaccharide, Biochem. J., 312, 839, 10.1042/bj3120839

Huet, 1987, Absorptive and mucus-secreting subclones isolated from a multipotent intestinal cell line (HT-29) provide new models for cell polarity and terminal differentiation, J. Cell Biol., 105, 345, 10.1083/jcb.105.1.345

van Berkel, 1997, N-Terminal stretch Arg2, Arg3, Arg4, and Arg5 of human lactoferrin is essential for binding to heparin, bacterial lipopolysaccharide, and DNA, Biochem. J., 328, 145, 10.1042/bj3280145

Molist, 1998, All HT-29 cell lines produce mainly heparan sulphate proteoglycan that is found partly in extracellular medium and associated to the cell membrane, Eur. J. Biochem., 254, 371, 10.1046/j.1432-1327.1998.2540371.x

Roiron, 1989, Lactoferrin-binding sites at the surface of HT29-D4 cells. Comparison with transferrin, Eur. J. Biochem., 186, 367, 10.1111/j.1432-1033.1989.tb15218.x

Nibbering, 2001, Human lactoferrin and peptides derived from its N terminus are highly effective against infections with antibiotic-resistant bacteria, Infect. Immun., 69, 1469, 10.1128/IAI.69.3.1469-1476.2001

Pejler, 1996, Lactoferrin regulates the activity of heparin proteoglycan-bound mast cell chymase: characterization of the binding of heparin to lactoferrin, Biochem. J., 320, 897, 10.1042/bj3200897

Wadstrom, 1999, Glycosaminoglycan-binding microbial proteins in tissue adhesion and invasion: key events in microbial pathogenicity, J. Med. Microbiol., 48, 223, 10.1099/00222615-48-3-223